"Chemical dependency treatment programs and services available at our Center City, Minnesota, campus include inpatient and outpatient drug and alcohol rehab, day treatment with sober living options, post-treatment recovery management support, and family education and guidance. The flagship drug rehab center continues to lead the way forward with evidence-based treatment practices and research-informed approaches, provided with the respectful, compassionate care that has set our programs apart from the start. We are in-network with most insurance providers. Don't wait, if you or a loved one are struggling with substance abuse, call today to speak confidentially with a recovery expert. You're not alone."

During the past decade, Hazelden Betty Ford Foundation conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hazelden Betty Ford Foundation" #1 collaborator was "Hazelden Betty Ford Foundation" with 2 trials as a collaborator, "Gaudenzia, Inc." with 1 trials as a collaborator and "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hazelden Betty Ford Foundation" are "Alcohol Use Disorder" (1 trials), "Opioid Use Disorder" (1 trials), "Opioid Withdrawal" (1 trials), "Opioid-use Disorder" (1 trials) and "Relapse" (1 trials). Many other conditions were trialed in "Hazelden Betty Ford Foundation" in a lesser frequency.

Most popular intervention types in "Hazelden Betty Ford Foundation" are "Drug" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acamprosate" (1 trials), "Clinical Outcomes and Questionnaires" (1 trials), "Extended-release injectable naltrexone" (1 trials), "Lofexidine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hazelden Betty Ford Foundation" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hazelden Betty Ford Foundation". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Hazelden Betty Ford Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hazelden Betty Ford Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".